Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...

In a move to drive innovation and regulatory responsiveness in agricultural biotechnology, the Southeast Asian Regional ...

Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

The 3D cell culture market is projected to witness remarkable expansion, reaching an estimated USD 2.26 billion by 2030 from ...

Amgen executives and elected officials hold a virtual groundbreaking for the biotech giant's planned $600 million science and innovation center. (Mike Harris / PCBT Staff) Hard hats on, shovels in ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to ...

As the EU prepares its first Biotech Act, experts say that Europe risks overlooking the role of biotechnology in food, a gap ...